These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7510910)

  • 1. Distribution of chlordecone to liver plasma membranes and recovery from hepatobiliary dysfunction in rats.
    Rochelle LG; Curtis LR
    Toxicology; 1994 Jan; 86(1-2):123-34. PubMed ID: 7510910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired biliary excretion of taurocholate associated with increased biliary tree permeability in mirex- or chlordecone-pretreated rats.
    Curtis LR; Hoyt D
    J Pharmacol Exp Ther; 1984 Dec; 231(3):495-501. PubMed ID: 6209385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlordecone pretreatment alters [14C]chlordecone and [14C]cholesterol transport kinetics in the perfused rat liver.
    Gilroy DJ; Carpenter HM; Curtis LR
    Fundam Appl Toxicol; 1994 Feb; 22(2):286-92. PubMed ID: 7516299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary excretion of sulfated bile acids and organic anions in zone 1- and zone 3-injured rats.
    Sasamoto T; Sano N; Takikawa H
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):26-31. PubMed ID: 16706808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible molecular mechanism of mirex-induced hepatobiliary dysfunction.
    Mehendale HM; Ho IK; Desaiah D
    Drug Metab Dispos; 1979; 7(1):28-33. PubMed ID: 35323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of endrin and endrin derivatives on hepatobiliary function and carbon tetrachloride-induced hepatotoxicity in male and female rats.
    Young RA; Mehendale HM
    Food Chem Toxicol; 1986 Aug; 24(8):863-8. PubMed ID: 3781435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlordecone altered hepatic disposition of [14C]cholesterol and plasma cholesterol distribution but not SR-BI or ABCG8 proteins in livers of C57BL/6 mice.
    Lee J; Scheri RC; Curtis LR
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):265-72. PubMed ID: 18387646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlordecone impairs Na(+)-stimulated L-[3H]glutamate transport and mobility of 16-doxyl stearate in rat liver plasma membrane vesicles.
    Rochelle LG; Miller TL; Curtis LR
    Toxicol Appl Pharmacol; 1990 Sep; 105(2):234-42. PubMed ID: 1699298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoproteins decrease the biliary concentration of chlordecone in isolated perfused pig liver.
    Soine PJ; Blanke RV; Chinchilli VM; Schwartz CC
    J Toxicol Environ Health; 1984; 14(2-3):319-35. PubMed ID: 6209411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of colchicine on hepatobiliary function in CCl4 treated rats.
    Rao CV; Mehendale HM
    Biochem Pharmacol; 1991 Nov; 42(12):2323-32. PubMed ID: 1764117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of bromotrichloromethane hepatotoxicity and lethality by chlordecone preexposure in the rat.
    Agarwal AK; Mehendale HM
    Fundam Appl Toxicol; 1982; 2(4):161-7. PubMed ID: 6193023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirex inhibits bile acid secretory function in vivo and in the isolated perfused rat liver.
    Teo S; Vore M
    Toxicol Appl Pharmacol; 1991 Jun; 109(1):161-70. PubMed ID: 1710079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in tissue distribution of chlordecone (kepone) in the rat following phenobarbital or SKF-525A administration.
    Aldous CN; Chetty CS; Desaiah D
    J Toxicol Environ Health; 1983 Mar; 11(3):365-72. PubMed ID: 6188850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of CCl4 hepatotoxicity and lethality by chlordecone in female rats.
    Agarwal AK; Mehendale HM
    Toxicology; 1983; 26(3-4):231-242. PubMed ID: 6190268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pivotal role of hepatocellular regeneration in the ultimate hepatotoxicity of CCl4 in chlordecone-, mirex-, or phenobarbital-pretreated rats.
    Kodavanti PR; Kodavanti UP; Faroon OM; Mehendale HM
    Toxicol Pathol; 1992; 20(4):556-69. PubMed ID: 1284994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset and recovery from chlordecone- and mirex-induced hepatobiliary dysfunction.
    Mehendale HM
    Toxicol Appl Pharmacol; 1981 Mar; 58(1):132-9. PubMed ID: 6165098
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the gender differences in 4,4'-methylenedianiline toxicity, distribution, and effects on biliary parameters.
    Dugas TR; Santa Cruz V; Liu H; Kanz MF
    J Toxicol Environ Health A; 2001 Mar; 62(6):467-83. PubMed ID: 11289319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.
    Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased permeability of the rat biliary tree by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment and protection by hepatoactive agents.
    Davidson MD; Fujimoto JM
    Toxicol Appl Pharmacol; 1987 Jan; 87(1):57-66. PubMed ID: 2432693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mirex exposure inhibits the uptake of estradiol-17 beta(beta-D-glucuronide), taurocholate, and L-alanine into isolated rat hepatocytes.
    Teo S; Vore M
    Toxicol Appl Pharmacol; 1990 Jul; 104(3):411-20. PubMed ID: 1696754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.